Colgate-Palmolive (CL) Tops Q4 EPS by 4c, Beats on Revenue; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Colgate-Palmolive Company Announces 4th Quarter and Full Year 2025 Results
January 30, 2026 6:55 AM ESTNEW YORK--(BUSINESS WIRE)-- Colgate-Palmolive Company (NYSE: CL):
Full Year
Net sales and Organic sales* increased 1.4%, including a 0.7% negative impact from lower private label pet volume GAAP EPS declined 25% to $2.63, driven by goodwill and intangible assets impairment charges related to the skin health business Base Business EPS* increased 3% to $3.69 Net cash provided by operations was a record $4,198 for the full year Returned $2.9 billion in cash to shareholders through dividends and share... More